Research on hemophilia treatments is yielding promising results, with various studies showing improved outcomes for patients with hemophilia A and B. Several new therapies, including gene therapies and prophylaxis treatments, have demonstrated efficacy and safety in clinical trials. The effectiveness of these treatments, including their ability to improve survival and control bleeding, is being reinforced by longer follow-up data and support from regulatory bodies.